Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Clinical
Phase IV
Phase IV
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase IV
First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar Gel (Repository Corticotropin Injection) for Severe Keratitis
Firstwordpharma News
-
December 16, 2019
- Advertisement -
MOST POPULAR
Alzheimer Patients at Swedish Clinics to be Included in Phase 3...
March 3, 2020
Novartis, Amgen and Banner End Alzheimer’s Program After Analysis Shows Patients’...
July 12, 2019
FDA rejects accelerated approval of Merck & Co., Eisai’s Keytruda, Lenvima...
July 9, 2020
Gilead’s potential coronavirus treatment gets FDA’s orphan drug label – FirstWord...
March 24, 2020
Load more
HOT NEWS
Others
Cool Science News! We Want to Know
Commercial
Endo Names Blaise Coleman President and Chief Executive Officer
Commercial
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement...
Deals
Burke Therapeutics, LLC Signs Exclusive US Marketing and Supply Agreement with...
